Veterinary Medicines

Clinacin 150 mg Tablets for Dogs

Authorised
  • Clindamycin hydrochloride
Download as PDF

Product identification

Medicine name:
Clinacin 150 mg Tablets for Dogs
Clinacin Vet. 150 mg tabletter
Active substance:
  • Clindamycin hydrochloride
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Clindamycin hydrochloride
    162.85
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01FF01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Denmark
Package description:
  • White high density polyethylene bottle with child resistant tamper evidentpolypropylene closure containing 10 tablets.
  • White high density polyethylene bottle with child resistant tamper evidentpolypropylene closure containing 16 tablets.
  • White high density polyethylene bottle with child resistant tamper evidentpolypropylene closure containing 20 tablets.
  • White high density polyethylene bottle with child resistant tamper evidentpolypropylene closure containing 30 tablets.
  • White high density polyethylene bottle with child resistant tamper evidentpolypropylene closure containing 50 tablets.
  • White high density polyethylene bottle with child resistant tamper evidentpolypropylene closure containing 80 tablets.
  • White high density polyethylene bottle with child resistant tamper evidentpolypropylene closure containing 100 tablets.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Well-established use application (Article 13a of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Chanelle Pharmaceuticals Manufacturing Limited
Marketing authorisation date:
Manufacturing sites for batch release:
  • Chanelle Pharmaceuticals Manufacturing Limited
Responsible authority:
  • Danish Medicines Agency
Authorisation number:
  • 32580
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0112/003
Concerned member states:
  • Austria
  • Denmark
  • Finland
  • France
  • Germany
  • Greece
  • Portugal
  • Spain
  • Sweden

Documents

Summary of Product Characteristics

English (PDF)
Published on: 3/05/2024
Download
Danish (, TABLETTER 150 MG)
Published on: 29/06/2023
Download